Business
Option Care Health Announces Preliminary Financial Results for Fourth Quarter and Full Year 2024 and Preliminary Financial Expectations for Full Year 2025
BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest
About this update from Option Care Health, Inc.
[{"type":"text","content":"BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2024. For the fourth quarter 2024, Option Care Health expects to report: Net revenue of approximately $1.34 billion to $1.35 billion, representing approximately 19.2% to 20.1% growth over the fourth quarter of 2023Net income of approximately $56.8 to $60.9 million, or diluted earnings per share of $0.33 to $0.36Adjusted net income of approximately $71.0 million to $76.8 million, or adjusted diluted earnings per share of $0.42 to $0.45Adjusted EBITDA of approximately $118.7 million to $121.7 million, representing approximately a 6.4% to 9.1% increase over the fourth quarter of 2023 For full year 2024, Option Care Health expects to report: Net revenue of approximately $4.99 billion to $5.00 billion, representing approximately 16.0% to 16.2% growth over the prior yearNet income of approximately $208.5 million to $212.6 million, or diluted earnings per share of $1.21 to $1.23Adjusted net income of approximately $268.3 million to $274.1 million, or adjusted diluted earnings per share of $1.55 to $1.59Adjusted EBITDA of approximately $441.0 million to $444.0 million, representing approximately a 3.7% to 4.4% increase over the prior yearCash flow from operations of at least $300 millionCash and cash equivalents of approximately $412.6 million Preliminary Full Year 2025 GuidanceFor the full year 2025, Option Care Health expects to deliver the following financial results: Net revenue of $5.2 billion to $5.4 billionAdjusted EBITDA of $445 million to $465 millionAdjusted EPS of $1.59 to $1.69 This preliminary guidance incorporates a negative gross profit impact of approximately $60 million to $70 million dollars related to the Stelara pricing adjustments discussed on the Company’s third quarter earnings call. The Company expects to provide further information regarding its full year 2025 financial guidance on its fourth quarter earnings call in February. New Share Repurchase Program AuthorizationIn the fourth quarter of 2024, the Company completed the remaining $90 million of share repurchases under its prior sh...